|
MAP3K9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.43470000002477E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.79850000000737E-05 |
| Normal-vs-Stage2 |
1.70743999999834E-05 |
| Normal-vs-Stage3 |
2.681900E-02 |
| Normal-vs-Stage4 |
1.94770999999427E-05 |
| Stage1-vs-Stage2 |
3.876200E-01 |
| Stage1-vs-Stage3 |
8.493800E-01 |
| Stage1-vs-Stage4 |
6.173800E-02 |
| Stage2-vs-Stage3 |
5.437400E-01 |
| Stage2-vs-Stage4 |
2.994200E-01 |
| Stage3-vs-Stage4 |
2.055800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.36099999995076E-06 |
| Normal-vs-AfricanAmerican |
3.79289999999921E-05 |
| Normal-vs-Asian |
1.24209999952107E-07 |
| Caucasian-vs-AfricanAmerican |
6.279200E-01 |
| Caucasian-vs-Asian |
2.244800E-03 |
| AfricanAmerican-vs-Asian |
1.455890E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.03062044746139E-12 |
| Normal-vs-Female |
1.436040E-01 |
| Male-vs-Female |
3.338800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.922960E-03 |
| Normal-vs-Extreme_Weight |
1.55140000845932E-09 |
| Normal-vs-Obese |
4.736700E-03 |
| Normal-vs-Extreme_Obese |
5.831000E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.096600E-01 |
| Normal_Weight-vs-Obese |
5.972600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.499800E-01 |
| Extreme_Weight-vs-Obese |
6.121700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.333600E-01 |
| Obese-vs-Extreme_Obese |
2.619400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.368200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.33320000000625E-05 |
| Normal-vs-Age(61-80Yrs) |
1.73909997513988E-09 |
| Normal-vs-Age(81-100Yrs) |
3.46939999951168E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.655800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.396200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.864300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.314570E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.280570E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.206200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.39499967133361E-10 |
| Normal-VS-Type2 PRCC |
1.65579999999999E-06 |
| Normal-VS-KIRP CIMP |
4.574400E-01 |
| Normal-VS-Unclassified PRCC |
1.479590E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.265600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.152800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.040400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.084050E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.137580E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.029400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.9853996224839E-10 |
| Normal-vs-N1 |
3.214000E-01 |
| Normal-vs-N2 |
5.060700E-03 |
| N0-vs-N1 |
1.266810E-01 |
| N0-vs-N2 |
9.525200E-01 |
| N1-vs-N2 |
1.721010E-01 |
|
|
